BioCision to Lead Discussion on “Last Mile” Challenges at Phacilitate Cell & Gene Therapy World 2016

Panel of experts to weigh in on issues facing the standardized delivery of cell therapy products

SAN RAFAEL, Calif.--()--BioCision, LLC, today announced they will host a panel discussion at Phacilitate’s Cell and Gene Therapy World 2016 conference in Washington, DC. The company has assembled a panel of leading cell therapy product development experts to discuss the challenges the industry faces in ensuring standardized and reproducible manufacturing, transportation and handling of sensitive cell-based therapeutics through the “last mile,” or point of care. The session, “Problems Inherent to the ‘Last Mile’ in Cell Therapy,” will be led by BioCision Senior Vice President of Research and Development, Eric Kunkel, PhD.

“Problems Inherent to the ‘Last Mile’ in Cell Therapy”

Kunkel joined BioCision in June 2014 and leads the R&D team that developed the company’s award-winning ThawSTAR® automated cell thawing technology, which has been rapidly adopted by cell therapy companies as a method of standardizing the thawing of cryopreserved therapeutics.

Confirmed panel participants include:

All registered attendees are welcome to participate. The interactive panel discussion will take place on Tuesday, January 26, 2016 from 10:20 to 11:20 a.m. in the McPherson and Franklin Room on the Independence Level in the Grand Hyatt Hotel.

BioCision will be exhibiting its award-winning automated cell thawing and transport products in booth #226.

About BioCision, LLC

BioCision is a life science research and development company that provides tools to standardize critical processes throughout the healthcare industry. BioCision’s award-winning portfolio of translational products can be integrated throughout research, development and manufacturing workflows, enabling consistent temperature control for sensitive therapeutics and biological samples. By addressing temperature stability, BioCision strives to improve the success of therapeutic discovery and development, and enable effective care delivery.

For more information visit, or visit the BioCision blog for news and expert insight at


Marla Kertzman, 209-852-9027

Release Summary

BioCision to Lead Discussion on “Last Mile” Challenges at Phacilitate Cell & Gene Therapy World 2016

BioCision, LLC